Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma

Journal of Neuro-Ophthalmology

Volumn 28, Issue 1, 2008, Pages 31-35

  Chen, Celia S ^a   Miller, Neil R ^a,b   Lane, Andrew ^a   Eberhart, Charles ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DIPLOPIA; DOSE RESPONSE; DRUG DOSE INCREASE; EYE EXAMINATION; EYE SWELLING; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; NATURAL KILLER T CELL; OCULOMOTOR NERVE DISEASE; ORBIT; PARANASAL SINUS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LYMPHOMA; VISUAL ACUITY;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FRONTAL LOBE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG NEOPLASMS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA, EXTRANODAL NK-T-CELL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; OCULOMOTOR NERVE; OCULOMOTOR NERVE DISEASES; ORBIT; PARANASAL SINUSES; PREDNISONE; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 40949142816     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3181674228     Document Type: Article

References (18)

1. Vega F, Lin P, Medeiros LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol 2005;9:340-5.
2. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
3. Luther N, Greenfield JP, Chadburn A, et al. Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature. J Neurooncol 2005;75:185-8.
4. Porcu P, Baiocchi RA, Magro C. Recent developments in the biology and therapy of T-cell and natural-cell lymphomas. Curr Opin Oncol 2003;15:353-62.
5. Jaffe ES, Ralfkiaer E Mature T-cell and NK-cell neoplasms. In: Jaffe ES, Harris NL, Stein H, et al., eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:191-235.
6. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas: Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11.
7. Mendenhall WM, Olivier KR, Lynch JW Jr, et al. Lethal midline granuloma-nasal natural killer/T-cell lymphoma. Am J Clin Oncol 2006;29:202-6.
8. Davison SP, Habermann TM, Strickler JG, et al. Nasal and nasopharyngeal angiocentric T-cell lymphomas. Laryngoscope 1996;106:139-43.
9. Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 1999;23:1356-69.
10. Woog JJ, Kim YD, Yeatts RP, et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 2006;113:140-7.
11. Coupland SE, Foss HD, Assaf C, et al. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 1999;106:2109-20.
12. Hon C, Kwok AK, Shek TW, et al. Vision-threatening complications of nasal T/NK lymphoma. Am J Ophthalmol 2002;134:406-10.
13. Jaffe ES, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol 2003;40:175-84.
14. Cheung MM, Chan JK, Wong KF. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol 2003;40:221-32.
15. Kim JE, Kim YA, Jeon YK, et al. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1. Pathol Int 2003;53:735-43.
16. Ohshima K, Suzumiya J, Shimazaki K, et al. Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 1997;31:444-50.
17. Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004;17:1097-107.
18. Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002;54:182-90.